SCHEMBL6850486

SCHEMBL6850486

CCCCCCCCCCOc1cnc(-c2ccc(OCCCCCCCC[Si](C)(C)C[Si](C)(C)C)cc2)nc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.55
RAB9A P51151 5/20 0.55
KDM4E B2RXH2 5/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
HSD17B10 Q99714 1/20 0.55
MAPT P10636 2/20 0.49
RARB P10826 3/20 0.46
ALDH1A1 P00352 4/20 0.44
HPGD P15428 3/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
HTT P42858 1/20 0.44
NR5A1 Q13285 1/20 0.43
CYP3A4 P08684 3/20 0.43
CYP2D6 P10635 3/20 0.43
CYP2C9 P11712 3/20 0.43
CYP2C19 P33261 3/20 0.43
CYP19A1 P11511 2/20 0.43
TP53 P04637 1/20 0.43
TSHR P16473 1/20 0.43
PLA2G4B P0C869 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9330980 0.91 NPC1 (0.58) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL9331459 0.91 NPC1 (0.58) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL9331328 0.91 NPC1 (0.58) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL9331355 0.91 NPC1 (0.58) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL6017416 0.90 RARB (0.51) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL8973361 0.90 RARB (0.51) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL6017512 0.90 RAB9A (0.54) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL6854491 0.90 RARB (0.51) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL6858725 0.90 RARB (0.51) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL6856931 0.90 NPC1 (0.55) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6783812-B2 USEFUL IN THE MANUFACTURE OF OPTICAL DEVICES; STABILITY DISPLAYTECH, INC. 2004-08-31 US disclosed
US-20020130299-A1 Alkyl silane liquid crystal compounds CITIZEN FINEDEVICE CO., LTD. (JP) 2002-09-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020130299-A1 Alkyl silane liquid crystal compounds SMURF1, SMURF2, DSTN NPC1 2373/4885RAB9A 3181/4885KDM4E 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.